
Medicus Pharma Seeks FDA Compassionate‑Use OK for Skinject in Gorlin Syndrome Patients
Medicus Pharma (NASDAQ: MDCX) is moving ahead with a plan to secure compassionate‑use approval from the Food and Drug Administration (FDA) for its fla...
Found 6,178 articles